|
Volumn 14, Issue 5, 1996, Pages
|
Interpretation of prospective trials in hypertension: Do treatment guidelines accurately reflect current evidence?
a,b a a a |
Author keywords
Cardiovascular risk; Coronary events; Cost effectiveness; Guidelines; Mild hypertension; Random controlled trials; Stroke
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
THIAZIDE DIURETIC AGENT;
AGE;
ANTIHYPERTENSIVE THERAPY;
BLOOD PRESSURE MONITORING;
BORDERLINE HYPERTENSION;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIABETES MELLITUS;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG SAFETY;
HEALTH CARE COST;
HEALTH CARE POLICY;
HUMAN;
HYPERTENSION;
MEDICAL DECISION MAKING;
META ANALYSIS;
NEW ZEALAND;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
RISK BENEFIT ANALYSIS;
SYSTOLIC HYPERTENSION;
TARGET ORGAN;
BLOOD PRESSURE;
CARDIOVASCULAR DISEASES;
HUMANS;
HYPERTENSION;
PRACTICE GUIDELINES;
PROSPECTIVE STUDIES;
RISK FACTORS;
TIME FACTORS;
|
EID: 0030480762
PISSN: 09521178
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (16)
|
References (5)
|